For citations:
Khokhlov A.L., Rybachkova J.V. The use of a new oral antiviral drug molnupiravir in the treatment of COVID-19 from a safety perspective. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2022;(3):35-51. (In Russ.) https://doi.org/10.37489/2588-0519-2022-3-35-51
Views PDF (Rus): 314
Email this article 